Immunic (IMUX) Exchange Rate Effect (2013 - 2026)
Immunic (IMUX) posted Exchange Rate Effect of -$193000.0 for Q1 2026, up 53.61% sequentially from -$416000.0 in Q4 2025, and down 142.05% YoY from $459000.0 in Q1 2025.
Powered by 
Analysis
Immunic (IMUX) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Immunic has reported Exchange Rate Effect for 14 years, with the latest figure at -$193000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 142.05% year-over-year to -$193000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$447000.0 (down 92.67% YoY) and the FY2025 annual result came in at $205000.0, up 139.65% from the prior year.
- Exchange Rate Effect climbed to -$193000.0 in Q1 2026 per IMUX's latest filing, from -$416000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $2.7 million in Q4 2022 and troughed at -$1.9 million in Q2 2022.
- A 5-year average of -$72705.9 and a median of $29000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect jumped 479.63% in 2022, then plunged 612.99% in 2024.
- Over 5 years, Exchange Rate Effect stood at $2.7 million in 2022, then sank by 78.5% to $573000.0 in 2023, then sank by 189.7% to -$514000.0 in 2024, then gained by 19.07% to -$416000.0 in 2025, then jumped by 53.61% to -$193000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$193000.0, -$416000.0, and $29000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Immunic | 546.30 Mn | 546.30 Mn | - | -402,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -402,000.00 |
| Mar 31, 2026 | -193,000.00 |
| Dec 31, 2025 | -416,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Dec 31, 2024 | -514,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Mar 31, 2024 | 174,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Sep 30, 2023 | -531,000.00 |
| Jun 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 143,000.00 |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | -1.64 Mn |
| Jun 30, 2022 | -1.92 Mn |
| Mar 31, 2022 | -103,000.00 |
| Dec 31, 2021 | -702,000.00 |
| Sep 30, 2021 | -1.13 Mn |